profit from every $100 of sales.
$0$100
Nutex Health
$189.19+1.58% today
+76.6% in 1 year
1-year low $87.011-year high $225.00
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $18.34 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Nutex Health sold, what it kept, and what it did with the cash.
Sales went from $219 million in 2022 to $875 million in 2025, with $70.8 million of profit last year.
SalesProfit
Nutex Health handed back 32% of the cash it generated last year.
$74M
Free cash flow 2025$246M
Bought back its own shares$5M
Paid as dividends$74M
Cash vs. debt$186M vs. $351M
Nutex Health vs. similar companies
Nutex Health grows the fastest of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Nutex Health | 18.3× · Fair price | ||
 GE HealthCare Technologies | 17.9× · Fair price | ||
 Tempus AI | No profit yet | ||
 BrightSpring Health Services | 75.8× · Very expensive | ||
 HealthEquity | 39.6× · Expensive |
AI analysis
An AI analyst reads Nutex Health's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 219 | 248 | 480 | 875 | |
| 15 | 35 | 196 | 444 | |
| -5 | -2 | 138 | 276 | |
| -394 | -15 | 149 | 288 | |
| -425 | -46 | 52 | 71 | |
| -100.50 | -10.50 | 9.71 | 10.48 | |
| 7.0% | 14.0% | 40.9% | 50.8% | |
| -2.1% | -0.6% | 28.7% | 31.5% | |
| -193.7% | -18.5% | 10.9% | 8.1% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 432 | 398 | 655 | 919 |
| Cash | 34 | 22 | 41 | 186 |
| Total debt | 267 | 276 | 340 | 351 |
| Total liabilities | 311 | 319 | 467 | 495 |
| 96 | 61 | 132 | 329 | |
| 4 | 4 | 5 | 7 | |
| -88.6% | -7.5% | 21.7% | 31.0% | |
| -443.1% | -74.5% | 39.3% | 21.5% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 51 | 1 | 23 | 248 | |
| 15 | 9 | 2 | 3 | |
| 36 | -8 | 21 | 246 | |
| Dividends paid | 51 | 5 | 6 | 74 |
| – | 0 | 0 | 5 | |
| 0 | 3 | 17 | 117 |
Valuation
- 18.3×
- 10.8×
- –
- 2.4×
- 1.5×
- 5.3×
- 5.1×
- 18.9%
- 5.5%
- 0.0%
Profitability
- 50.8%
- 31.5%
- 8.1%
- 33.2%
- 26.6%
- -12.8%
- 31.4%
- 10.1%
- 35.7%
- –
Growth
- +58.6%
- –
- +1,077.9%
- –
- +12.2%
Financial health
- 0.5×
- 1.01
- 36.5%
- 13.3×
- 3.14
- 3.12
- 0.92
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 4%of 958
Top 8%of 888
Top 31%of 600
Top 10%of 889
Top 3%of 987
What analysts expect
- Average price target
- $205.00
- Range
- $205.00 – $205.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 30, 2026 | 6.52 | 3.99 | +63.4% |
| Mar 5, 2026 | 1.61 | 5.56 | −71.0% |
| Nov 19, 2025 | 7.76 | 1.81 | +328.7% |
| Oct 22, 2025 | -2.95 | -1.43 | −105.8% |
| May 13, 2025 | 2.56 | 3.04 | −15.8% |
| Mar 31, 2025 | 11.12 | -0.12 | +9,366.7% |
| Nov 8, 2024 | -1.72 | -0.24 | −616.7% |
| Aug 8, 2024 | -0.07 | -0.29 | +75.9% |
News
Nutex outlines 3 to 5 hospitals per year growth, with 2 openings targeted in Q4 2026Seeking Alpha · Nov 7, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
5/7Passes 5 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
62Pass
Benjamin Graham
54No pass
Philip Fisher
63Pass
Peter Lynch
81Pass
Joel Greenblatt
70Pass
Charlie Munger
53No pass
Terry Smith
60Pass
Questions about Nutex Health
Is Nutex Health a good stock to buy?
A solid business at a fair price. 5 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Nutex Health AI analysis
What does Nutex Health do?
Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. It is in Medical - Healthcare Information Services.
Does Nutex Health pay a dividend?
Yes. In 2025 it paid out $74.3 million in dividends.
Is Nutex Health stock halal?
Yes. Nutex Health passes our halal screen: its business is permitted and its debt is 27% of its market value, under the 30% limit. How we check
How has Nutex Health stock done over the past year?
Up 76.6% over the past twelve months, to $189.19. It traded between $87.01 and $225.00 and is 15.9% below its high.
Who are Nutex Health's competitors?
The largest listed companies in the same industry are GE HealthCare Technologies, Tempus AI, BrightSpring Health Services and HealthEquity. The peers table on this page compares their profit, growth and price with Nutex Health's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.